Next Article in Journal
Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma
Next Article in Special Issue
Cancer Pain Management: A Narrative Review of Current Concepts, Strategies, and Techniques
Previous Article in Journal
Real-World Outcomes of Stage IV NSCLC with PD-L1 ≥ 50% Treated with First-Line Pembrolizumab: Uptake of Second-Line Systemic Therapy
Previous Article in Special Issue
Research in Perioperative Care of the Cancer Patient: Opportunities and Challenges
 
 
Review

Article Versions Notes

Curr. Oncol. 2023, 30(6), 5309-5321; https://doi.org/10.3390/curroncol30060403
Action Date Notes Link
article xml file uploaded 26 May 2023 07:27 CEST Original file -
article xml uploaded. 26 May 2023 07:27 CEST Update https://www.mdpi.com/1718-7729/30/6/403/xml
article pdf uploaded. 26 May 2023 07:27 CEST Version of Record https://www.mdpi.com/1718-7729/30/6/403/pdf
article html file updated 26 May 2023 07:29 CEST Original file https://www.mdpi.com/1718-7729/30/6/403/html
Back to TopTop